GC CELL CORPORATION

Business Segments GC Cell Corporation

Stocks

A144510

KR7144510005

Healthcare Facilities & Services

End-of-day quote Korea S.E. 2026-09-21			5-day change	1st Jan Change
14,230.00 ^KRW	-3.13%		-1.18%	-42.74%

08-14	GC Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	GC Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (KRW)

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025
CDMO				492M	7.68B	5.71B	5.06B	-
Immuno-Anticancer Drug				6.28B	30.67B	34.94B	38.1B	-
Cell Therapy				7.92B	6.58B	13.8B	1.31B	-
Acceptance of Specimen Service				133B	161B	94.19B	83.53B	-
Clinical Consignment				-	-	-	-	-
Other				1.14B	1.31B	2.18B	1.76B	-
Product Sales				5.83B	7.26B	8.4B	7.82B	-
Biologistics				12.21B	19.24B	25.82B	34.42B	-
Cell Storage				1.43B	1.94B	2.51B	2.45B	-

Geographical breakdown of sales (KRW)

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025
Japan				335M	1.26B	1.54B	1.47B	-
USA				8.5B	13.72B	20.13B	5.53B	-
Other				-	1.73B	667M	1.76B	-
Overseas				-	-	-	-	-
South Korea				159B	219B	165B	166B	-

-40%: Exceptional extension

SEIZE THE OFFER!

×